EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
复制标题
DOI：
10.1007/s00259-009-1266-y
复制
发表时间：
2009-12-01
影响因子：
9.1
通讯作者：
Van Laere, Koen J.
中科院分区：
文献类型：
--
作者：
Kapucu, Oezlem L.;Nobili, Flavio;Van Laere, Koen J.
这些指南总结了欧洲核医学协会神经影像委员会（ENC）的当前观点。该指南的目的是帮助核医学从业者在使用Tc-99 m标记的放射性药物进行脑灌注单光子发射计算机断层扫描（SPECT）研究时提出建议、执行、解释和报告结果。其目的是实现高质量的脑灌注SPECT成像标准，这将增加该技术在临床实践中的诊断影响。本文件取代了2001年发布的指南的前一版本，该版本的灵感来自核医学学会脑灌注SPECT程序指南[1]、核医学学会脑成像理事会的观点[2]以及欧洲国家专家的个人经验。该指南旨在提供专门适应欧洲实践的信息。所提供的信息应在当地条件和法规的背景下加以考虑。
These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners when making recommendations, performing, interpreting, and reporting the results of brain perfusion single photon emission computed tomography (SPECT) studies using Tc-99m-labelled radiopharmaceuticals. The aim is to achieve a high quality standard for brain perfusion SPECT imaging, which will increase the diagnostic impact of this technique in clinical practice. The present document replaces a former version of the guideline published in 2001 which was inspired by the Society of Nuclear Medicine Procedure Guideline for Brain Perfusion SPECT [1], the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines are intended to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.